The biotech start-up Lygos recently announced that it has raised US$13 million in Series A funding led by OS Fund and IA Ventures, with participation from First Round Capital, Y Combinator’s Continuity Fund, Fifty Years, Vast Ventures and various angel investors to produce biobased malonic acid.… Login to continue

Login or sign up